Patents by Inventor John Scott Karolchyk

John Scott Karolchyk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170105931
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Application
    Filed: December 30, 2016
    Publication date: April 20, 2017
    Inventor: John Scott Karolchyk
  • Publication number: 20170049721
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: August 25, 2016
    Publication date: February 23, 2017
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Publication number: 20160354308
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 8, 2016
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Publication number: 20160279055
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventors: Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters, Dennis Elias Saadeh
  • Publication number: 20150335704
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Application
    Filed: May 21, 2015
    Publication date: November 26, 2015
    Applicant: IMPRIMIS PHARMACEUTICALS, INC.
    Inventor: John Scott KAROLCHYK
  • Publication number: 20150119440
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 30, 2015
    Inventors: John Scott Karolchyk, Mark L. Baum
  • Publication number: 20150024996
    Abstract: Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
    Type: Application
    Filed: March 27, 2014
    Publication date: January 22, 2015
    Applicant: IMPRIMIS PHARMACEUTICALS, INC.
    Inventors: Jeffrey T. LIEGNER, John Scott Karolchyk, Bernard Covalesky, Richard Dilzer, Kallan Peters